The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling
Open accessAbstract
Recently, drug nanosuspensions have shown a potential for ophthalmic delivery. In this study, a hydrocortisone (HC) nanosuspension (NS) was developed using microfluidic nanoprecipitation as a recent, simple and cost-effective bottom-up technique of drug nanonization. For comparison, a second HC NS was prepared by top-down wet milling procedures. The produced nanosuspensions were characterized for particle size, shape and zeta potential. HC nanosuspensions of approximately 300nm particle size were produced by adjusting experimental conditions of the two processing techniques. Results of X-ray diffraction and differential scanning calorimetry revealed that HC maintained the crystalline structure upon milling, while predominant amorphous particles were generated after precipitation. Ocular bioavailability of HC nanosuspensions was assessed in albino rabbits using HC solution as a control. A sustained drug action was maintained up to 9h for the nanosuspensions compared to 5h for the drug solution. The precipitated and milled NS achieved comparable AUC(0-9h) values of 28.06±4.08 and 30.95±2.2, respectively, that were significantly (P<0.05) higher than that of HC solution (15.86±2.7). After 2 months storage at room temperature, the milled HC NS showed good stability with no discernable changes in particle size, whereas the particle size of the precipitated HC NS increased to 440nm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles
Karnik, R., Gu, F., Basto, P., Cannizzaro, C., Dean, L., Kyei-Manu, W., Langer, R., & Farokhzad, O. C. (2008) · Nano Letters · doi:10.1021/nl801736q · Cited by 887
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Lab-on-a-chip for drug development
Weigl, B. H., Bardell, R. L., & Cabrera, C. R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00223-5 · Cited by 481
Polymeric nanoparticulate system: A potential approach for ocular drug delivery
Nagarwal, R. C., Kant, S., Singh, P. N., Maiti, P., & Pandit, J. K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.018 · Cited by 481
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery
Gupta, H., Aqil, M., Khar, R. K., Ali, A., Bhatnagar, A., & Mittal, G. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.10.004 · Cited by 367
Self-citationNanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Verma, S., Gokhale, R., & Burgess, D. J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.005 · Cited by 354
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 285
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Ali, H. S. M., York, P., & Blagden, N. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.029 · Cited by 225
Self-citationNanomedicines for ocular NSAIDs: safety on drug delivery
Araújo, J., Gonzalez, E., Egea, M. A., Garcia, M. L., & Souto, E. B. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.003 · Cited by 223
Zhao, H., Wang, J.-X., Wang, Q.-A., Chen, J.-F., & Yun, J. (2007) · Industrial & Engineering Chemistry Research · doi:10.1021/ie070498e · Cited by 169
Yang, W. P., Johnston, K. P., & Williams, R. O. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.01.011 · Cited by 140
Intraocular Pressure Elevation Associated with Inhalation and Nasal Corticosteroids
Opatowsky, I., Feldman, R., Gross, R. L., & Feldman, S. T. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31039-1 · Cited by 132
Amorphous Drug Nanosuspensions. 3. Particle Dissolution and Crystal Growth
Lindfors, L., Skantze, P., Skantze, U., Westergren, J., & Olsson, U. (2007) · Langmuir · doi:10.1021/la700811b · Cited by 127
Ganta, S., Paxton, J. W., Baguley, B. C., & Garg, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.022 · Cited by 122
Yang, W. P., Tam, J. M., Miller, D. A., Zhou, J., McConville, J. T., Johnston, K. P., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.003 · Cited by 112
Nanoparticles in Drug Delivery: Potential Green Nanobiomedicine Applications
Ravichandran, R. (2009) · doi:10.1080/19430850903430427 · Cited by 78
Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications
Deng, Z., XU, S., & Li, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.001 · Cited by 63
Bary, A. R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00108-9 · Cited by 49
Zhang, H., Wang, J., Shao, L., & Chen, J. (2010) · Industrial & Engineering Chemistry Research · doi:10.1021/ie901365w · Cited by 38
Kamiya, S., Kurita, T., Miyagishima, A., & Arakawa, M. (2009) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802698786 · Cited by 31
Cited by
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
Junyaprasert, V. B., & Morakul, B. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.005 · Cited by 443
Thorat, A. A., & Dalvi, S. V. (2012) · Chemical Engineering Journal · doi:10.1016/j.cej.2011.12.044 · Cited by 438
Drug nanocrystals in the commercial pharmaceutical development process
Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.034 · Cited by 432
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Metadata
- Authors
- Ali, H. S. M., York, P., Ali, A. M. A., & Blagden, N.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 149
- Issue
- 2
- Pages
- 175-181
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1969644888
- Cited by
- 253
- References
- 28
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.